Biomarker driven trials are clinical studies that utilize specific biological markers to select and stratify patients. These biomarkers are typically genetic, protein, or other molecular signatures that provide information about the tumor's characteristics. By targeting these specific alterations, the trials aim to improve the efficacy of the treatment and minimize adverse effects.
